Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)

By Gallanagh Siobhan   Castagno Davide   Wilson Ben   Erdmann Erland   Zannad Faiez   Remme Willem   Lopez-Sendon José   Lechat Philippe   Follath Ferenc   Höglund Christer   Mareev Viacheslav   Sadowski Zygmunt   Seabra-Gomes Ricardo   Dargie Henry   McMurray John  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 77-85

Springer Publishing Company

Access to resources Recommend Favorite

Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in Sweden: Analysis Using Data from the Cardiac Insufficiency Bisoprolol Study II Trial

By Ekman M.   Zethraeus N.   Jönsson B.  

PharmacoEconomics, Vol. 19, Iss. 9, 2001-01 ,pp. : 901-916

Adis International

Access to resources Recommend Favorite

One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients: A Randomized, Double-Blind Study

By Parrinello Gaspare  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 591-600

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in Germany: Economic Evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study

By Schädlich P.K.   Brecht J.G.  

PharmacoEconomics, Vol. 13, Iss. 6, 1998-06 ,pp. : 719-730

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

By Murphy N.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 607-622

Adis International

Access to resources Recommend Favorite